Tech Company Financing Transactions

Arsia Therapeutics Funding Round

Polaris Partners joined a $1 million venture round for Arsia Therapeutics. The funding round was announced on 6/30/2015.

Transaction Overview

Company Name
Announced On
6/30/2015
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1000 Winter St. 3350
Waltham, MA 02451
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Biologics are protein-based antibody drugs used to treat cancers, autoimmune disorders, and other chronic diseases. Comprised of very large molecules and typically delivered intravenously in high concentrations over several hours, these therapeutics are usually administered in hospitals settings or infusion clinics.
Profile
Arsia Therapeutics LinkedIn Company Profile
Social Media
Arsia Therapeutics Company Twitter Account
Company News
Arsia Therapeutics News
Facebook
Arsia Therapeutics on Facebook
YouTube
Arsia Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Co-Founder
Alan Crane
  Alan Crane LinkedIn Profile  Alan Crane Twitter Account  Alan Crane News  Alan Crane on Facebook
Co-Founder
Robert Langer
  Robert Langer LinkedIn Profile  Robert Langer Twitter Account  Robert Langer News  Robert Langer on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2015: Rithmio venture capital transaction
Next: 6/30/2015: Kentik venture capital transaction

 

Share this article

 


News on VC Transactions

We document tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary